Perioperative hemodynamic protective assessment of adaptive support ventilation usage in pediatric surgical patients

Dmytro Dmytriiev; Mykola Melnychenko; Oleksandr Dobrovanov; Oleksandr Nazarchuk; Marian Vidiscak

doi:10.4266/acc.2022.00297

Articles

Page Path: HOME > Acute Crit Care > Volume 37(4); 2022 > Article

Original Article Pediatrics Perioperative hemodynamic protective assessment of adaptive support ventilation usage in pediatric surgical patients: Dmytro Dmytriiev¹, Mykola Melnychenko¹, Oleksandr Dobrovanov^2,3, Oleksandr Nazarchuk^4,5, Marian Vidiscak³; Acute and Critical Care 2022;37(4):636-643.
DOI: https://doi.org/10.4266/acc.2022.00297
Published online: October 19, 2022

¹Department of Anesthesiology and Intensive Care, National Pirogov Memorial Medical University, Vinnytsya, Vinnytsia, Ukraine

²A. Getlik Clinic for Children and Adolescents, Slovak Medical University and University Hospital of Medicine, Bratislava, Slovakia

³Slovak Medical University in Bratislava, Slovakia

⁴Department of Microbiology, National Pirogov Memorial Medical University, Vinnytsya, Vinnytsia, Ukraine

⁵Municipal non-profit enterprise “Vinnytsya Regional Clinical Hospital Vinnytsya Regional Council”, Vinnytsya, Ukraine

Corresponding author: Oleksandr Dobrovanov A. Getlik Clinic for Children and Adolescents, Slovak Medical University and University Hospital of Medicine, st. Antolska 11, 85107 Bratislava, Slovakia Tel: +421-9-4914-8755, E-mail: brovan.oleksandr@gmail.com

• Received: March 3, 2022 • Revised: July 2, 2022 • Accepted: August 6, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

3,101 Views
137 Download
1 Web of Science
3 Crossref
5 Scopus

prev next

Full Article

Download PDF

Abstract
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
KEY MESSAGES
NOTES
References

Abstract

Background
The aim of this study was to evaluate the hemodynamic protective effects of perioperative ventilation in pressure-controlled ventilation (PCV) and adaptive support ventilation (ASV) modes based on non-invasive hemodynamic monitoring indicators.
Methods
The study included 32 patients who were scheduled for planned open abdominal surgery. Depending on the chosen ventilation strategy, patients were included in two groups of PCV mode ventilation (n=14) and ASV mode ventilation (n=18). The hemodynamic effects of the ventilation strategies were assessed by estimated continuous cardiac output (esCCO) and cardiac index (esCCI).
Results
Preoperative cardiac output (CO) was 6.1±1.3 L/min in group 1 patients and 6.3±0.8 L/min in group 2 patients, and preoperative cardiac index (CI) was 3.9±0.4 L/min/m² in group 1 patients and 3.8±0.8 L/min/m² in group 2 patients. The ejection fraction (EF) in group 1 subjects was 55.4%±0.3%; this rate was 56.5%±0.5% in group 2 subjects. Group 1 patients experienced a 14.7% CO decrease to 5.2±0.7 L/min, a 17.9% CI decrease to 3.2±0.6 L/min/m², and a 12.8% mean arterial pressure decrease to 82.3±9.4 mm Hg 30 minutes after the start of surgery. One hour after the start of surgery, the CO mean values of group 2 patients were lower than baseline by 7.9% and differed from the dynamics of patients in group 1, in whom CO was lower than baseline by 13.1%. At the end of the operation, the CO values were lower than baseline by 11.5% and 6.3% in patients of groups 1 and 2, respectively. Our data showed that the changes in EF during and after surgery correlated with CO indicators determined by the esCCO.
Conclusions
In our study, perioperative ventilation in ASV mode was more protective than PCV mode and was characterized by lower tidal volume (16.2%) and driving pressure (12.1%). Hemodynamically-controlled mechanical ventilation reduces the negative impact of cardiopulmonary interactions.
Keywords: adaptive support ventilation; estimated continuous cardiac output; hemodynamic; perioperative period; pressure-controlled ventilation; ventilation

INTRODUCTION

Most patients require mechanical ventilation (MV) during surgery, and optimization of intraoperative MV can reduce the incidence of postoperative pulmonary complications and improve treatment outcomes. Lung ventilators are becoming more technical and difficult to use, and low tidal volume (VT) and low positive end-expiratory pressure (PEEP) are needed when adjusting the ventilation mode. The VT needs to be calculated based on ideal, not actual, body weight. There is currently no clear evidence of the benefits of any ventilation mode.

Age, American Society of Anesthesiology (ASA) grade, functional status, type and duration of surgery, and perioperative ventilation tactics affect treatment outcome. Therefore, it is important to study protective respiratory strategies to reduce morbidity, mortality, and length of hospital stay [1]. Volume and pressure regimens are widely used in perioperative ventilation, but the superior regimen regarding patient outcomes has not been determined. With volume-controlled ventilation, a predetermined VT is supplied during inspiration via a steady flow that stops when the target volume is reached. In volume-controlled ventilation, airway pressure is a dependent variable that is affected by dynamic airway resistance and lung flexibility. Increasing resistance or decreasing flexibility can increase airway pressure, increasing the risk of barotrauma and lung damage caused by the ventilator. Abrupt changes in respiratory system compliance may occur during surgical patient positioning, leading to pneumoperitoneum during laparoscopic intervention.

With pressure-controlled ventilation (PCV), the physician selects the target peak inspiratory pressure, and the device delivers a flow that stops when the set pressure level is reached. VT is a dependent variable, and VT abnormalities can lead to dangerous hypo- or hyperventilation. Adaptive support ventilation (ASV) mode has a closed control cycle based on the mechanics of the respiratory system. Resistance and compliance are measured continuously with each breath to control the pressure and deliver the target volume. The physician enters data such as patient sex and height, and the system automatically calculates the body weight index and the appropriate volume of minute ventilation. The system then sets the target VT and respiration rate (RR) based on the feedback signal. However, VT and RR are not constant but change according to changes in resistance, compliance, and expiration constant to ensure the target volume.

With MV, there are changes in intrapleural and intrathoracic pressure and lung volume, and these changes affect the cardiovascular system. Atrial filling (preload), resistance to ventricular emptying (postload), heart rate, and myocardial contractility are all affected. Changes in intrathoracic pressure affect intrathoracic structures including the heart and pericardium and large arteries and veins. As the volume increases, the lungs exert increasing force on the heart, chest wall, and diaphragm. At the same time, the chest wall expands outward; the diaphragm lowers; and the heart, pericardium, and coronary arteries are compressed by the lungs [2]. Excessive VTs cause pulmonary bloating, which leads to impaired ventricular filling with clinical manifestations of cardiac tamponade. An acute decline in systemic venous return after starting MV is one of the most common cardiopulmonary interactions encountered in the ICU and the cause of "acute cardiovascular collapse" after intubation, a dangerous condition especially in patients with hypovolemia and septic vasodilation.

The effect of MV on the heart and hemodynamics depends on the chosen mode of ventilation and on changes in intrathoracic pressure and lung volume [3]. Different ventilatory regimens may have the same effect on hemodynamics if the intrathoracic pressure and lung volume are equal. Cardiac output (CO) is unchanged at equal VT and increases with decreasing volume [4,5]. Studies show that, when the lungs swell, the CO decreases [6]. The aim of this study was to evaluate the hemodynamic protective effects of PCV and ASV mode perioperative ventilation based on non-invasive hemodynamic monitoring indicators and ultrasound examination data.

MATERIALS AND METHODS

Following approval by the Ethics Committee of National Pirogov Memorial Medical University, Vinnytsya, Vinnytsia, Ukraine (Protocol No. 3/111), 32 patients who were scheduled for planned open abdominal surgery for tumors of the gastrointestinal tract with total intravenous anesthesia and MV were recruited. This study was conducted with written consent of all patients. Moral and ethical standards of the Helsinki Declaration of Human Rights, the Council of Europe Convention on Human Rights and Biomedicine, and relevant laws and orders of the Ukraine Ministry of Health were maintained. A brief summary of patient selection is given in Figure 1.

All patients received a standard regimen of preoperative preparation and infusion therapy during surgery. The main criteria for inclusion in the study were duration of surgery longer than 2 hours, need for postoperative ventilation for more than 12 hours, ASA patient physical status of I–III, and provision of informed consent to participate. Exclusion criteria were severe peripheral microcirculation disorder, clinically significant cardiac arrhythmia, significant damage to peripheral arteries, severe heart valve dysfunction, duration of surgery less than 2 hours, ASA physical status of IV–V, or patient refusal to participate.

The hemodynamic effects of the ventilation strategies were assessed by continuous non-invasive measurement of estimated continuous cardiac output (esCCO) and cardiac index (esCCI) by a Nihon Kohden monitor (Nihon Kohden Corp., Tokyo, Japan) and were calculated based on pulse oximetry data, ECG signals, and pulse wave transit time [7]. Additionally, the hemodynamic effects of the ventilation strategies were assessed by echocardiographic measurements with the Esaote MyLab Alpha (Esaote, Italy) using a 3-7 MHz cardiac sensor. The evaluated parameters were the linear dimensions of the right and left ventricles, end-systolic and end-diastolic volumes, and ejection fraction (EF). Diameter and degree of inferior vena cava collapse and pulmonary artery pressure as determined by estimation of maximum tricuspid regurgitation were measured.

Depending on the chosen ventilation strategy, patients were included in one of two study groups, assignment to which occurred through a random and blind selection method. The first group (n=14) included patients who underwent PCV ventilation during surgery, and the second group (n=18) included patients who underwent ASV ventilation during surgery. In both groups, a Hamilton C1 ventilator was used for MV; an intravenous anesthetic, Propofol 1%; a narcotic analgesic, Fentanyl 0.005%; and a muscle relaxant, Atracurium, were used for anesthesia.

Stages of research is as follows: before the operation, 30 minutes after the start of the operation, 1 hour after the start of the operation, at the end of the operation, and 12 hours after the end of the operation. A mathematical analysis of the results of the study was performed using computer programs Microsoft Excel 2016 (Redmond, WA, USA) and Statistica 5.5 (TIBCO Software Inc, Palo Alto, CA, USA). Comparison of statistical characteristics of groups and of dynamics of observation was performed using parametric and nonparametric criteria (considering the law of distribution). Results at P <0.05 were considered statistically significant. In addition, multivariate analysis of variance (MANOVA) with a probability less than 5% was used to determine the effect of the selected ventilation mode on ventilation and hemodynamic parameters and to establish relationships between ventilation and hemodynamic parameters.

RESULTS

A total of 32 patients was examined. Demographic indicators did not differ significantly and are presented in Table 1. The initial settings of the ventilator were as follows: (1) group 1: PCV mode; inspiratory pressure–VT=6–8 ml/kg, RR=10–14/min, inspiratory-to-expiratory ratio=1:3, PEEP=3 cm H₂0, and FiO₂=0.4 and (2) group 2: ASV mode; MinVol=100%, PEEP=3 cm H₂0, and FiO₂=0.4.

Intraoperative monitoring data are presented in Table 2. Data from hemodynamic monitoring by the esCCO method and ventilation status of patients are shown in Table 3 at the start of the operation, 30 minutes after the start of the operation, 60 minutes after the start of the operation, at the end of the operation, and after 12 hours of MV postoperation. Driving pressure (ΔP), depending on Ppeak, was significantly lower in patients under the ASV regimen than in those under the PCV regimen (P<0.05). Respiratory volume was 7.4±1.2 ml/kg in group 1 and 6.2±0.8 ml/kg in group 2.

In order to enhance hemodynamic monitoring and to establish the relationships between the data of non-invasive monitoring by esCCO on ultrasound, the following indicators were determined. Before the operation, group 1 individuals had a CO of 6.1±1.3 L/min; the CO of the patients in group 2 was 6.3±0.8 L/min. The cardiac index (CI) of group 1 and group 2 patients was 3.9±0.4 L/min/m² and 3.8±0.8 L/min/m², respectively. The mean arterial pressure (MAP) values were 94.4±9.4 mm Hg and 95.3±9.8 mm Hg for group 1 and group 2 patients, respectively; the heart rate was 86.6±9.4 beats/min and 89.5±9.2 beats/min. The EF in group 1 was 55.4%±0.3%, and the value was 56.5%±0.5% in the second group. All indicators in both groups corresponded to the hyperdynamic type of blood circulation, likely due to the psycho-emotional experience of patients before surgery.

After 30 minutes from the start of surgery, group 1 patients experienced a decrease in hemodynamic parameters: CO decreased by 14.7% to 5.2±0.7 L/min, CI decreased by 17.9% to 3.2±0.6 L/min/m², and MAP decreased by 12.8% to 82.3±9.4 mm Hg. Heart rate decreased by 12.6% to 75.7±9.8 beats/min. Echocardiography indicated that EF in patients of the first group decreased by 7.6%. Patients in the second group also recorded a slight decrease in the measured values relative to baseline at 30 minutes after the start of the surgery. CO decreased by 12.7% to 5.5±1.1 L/min., CI decreased by 18.4% to 3.1±0.4 L/min/m², and EF decreased by 5.4% from baseline. MAP fluctuated within 14.8%, and its mean value was 81.2±9.2 mm Hg with a decrease in heart rate of 18.9% from baseline (72.6±8.8 beats/min).

One hour after the start of surgery, the mean CO values of patients in the second group were lower than baseline by 7.9% and differed from the dynamics of patients in the first group, in whom CO increased compared to the previous period but remained lower than baseline by 13.1%. At the end of the operation, the CO values were lower than baseline in patients of groups 1 and 2 by 11.5% and 6.3%, respectively. Twelve hours after surgery, the CO was lower than baseline by 6.6% and 3.1% in patients of the first and second groups, respectively; however, compared to the previous period, CO growth was 5.6% and 3.4%,. According to echocardiography, EF decreased in patients of the first group by 5.3% and patients of the second group by 1.6%.

The CO dynamics determined by the esCCO method during and after surgery in relation to the initial level of 100% are shown in Figure 2. The changes in EF during and after surgery in relation to the initial level of 100% are shown in Figure 3. The dynamics of CI in patients with surgical pathology were the same between groups at all stages of surgical treatment. This indicated an adequate level of fluid resuscitation of all patients. Evaluation of ultrasound data on the diameter of the inferior vena cava and the degree of its collapse confirmed these data (Table 4).

The volume of infusion during the operation using balanced crystalloid solutions in group 1 patients was 1.9±0.6 L, and that in patients of group 2 was 1.8±0.4 L. Body weight was 27.8±1.3 kg for patients in group 1 and 25.1±1.6 kg for patients in group 2. SpO₂ level was within normal limits throughout the observation period. The level of diuresis was adequate and exceeded 0.5 ml/hr. In continuous measurement of CO during surgery of group 2 patients, stable hemodynamic parameters were achieved, with a 9.7% decrease in infusion therapy compared with group 1.

The MANOVA results show that the chosen ventilation mode significantly affected both the ventilation parameters [VT, Ppeak, ΔP–F (3, 28)=20,507; P<0.0001; Wilk's Λ=0.313] and the hemodynamic parameters [esCCO, EF–F (2, 29)=853,996; P<0.0001; Wilk's Λ=0.017]. In addition, the parameters of hemodynamics (esCCO, EF) were significantly influenced by the ventilation parameters VT [F (50, 10)=6,830; P<0.001; Wilk's Λ=0.313], Ppeak [F (2, 9)=241,898; P<0.0001; Wilk's Λ=0.057], and ΔP [F (48, 12)=4.597; P<0.01; Wilk's Λ=0.003].

DISCUSSION

We conducted this study to research the features of intraoperative ventilation and to compare PCV and ASV regimens in surgical patients. We found that traditional PCV ventilation VT and hemodynamic monitoring results were different from the results using the ASV regimen. Ventilation should involve low VTs based on body weight index, moderately low PEEP, and the minimum possible FiO₂ [1]. This ventilation tactic prevents postoperative pulmonary complications [8-11]. There is evidence that this approach improves postoperative respiratory function [11] and clinical results [8,10].

In our study, the SpO₂ rate did not differ statistically between the two groups; however, PaO₂ during surgery was higher in patients receiving the PCV regimen (Table 3). Hyperoxia causes systemic vasoconstriction and reduces microcirculation [12,13]. Those reduce CO and organ perfusion; as heart rate decreases, systemic vascular resistance increases and capillary permeability decreases [14]. Therefore, higher PaO₂ level is not always associated with better oxygenation of tissues and organs.

According to the ARDSnet protocol, ventilation is considered protective if the VT is 4–8 ml/kg of ideal body weight, plateau pressure is <30 cm H₂O, and ΔP is <15 cm H₂O. In our study, VT was 16.2% lower and ΔP was 12.1% lower in the ASV group, depending on Ppeak level (P<0.05).

Based on patient data and respiratory mechanics (resistance, compliance, and autoPEEP), the safest ventilation parameters are automatically selected with the aim of target minute ventilation. Therefore, ASV can be used in patients with normal lungs and with restrictive or obstructive pulmonary pathology [15-18].

One of the additional benefits of ASV is early recognition of spontaneous breathing [19]. Studies show faster weaning times, fewer ASV manipulations, and fewer alarms than conventional ventilation modes [20]. In our study, with the same duration of surgery, the duration of anesthesia was shorter in patients of the second group, which may have been due to better synchronization of the device with the patient. At 60 minutes after the beginning and at the end of the operation, a more pronounced decrease in CO was observed in patients of the first group compared to baseline (Table 3). Analyzing the CO values at the end of the operation and 12 hours after the operation, the CO almost doubled in patients of the first group compared to the group in which the ASV mode was used.

As in Figures 2 and 3, the same dynamics of change and correlation of CO indicators determined by the esCCO method and ultrasonic EF parameters were observed between groups. Heart rate and CI did not differ significantly between the two groups, which indicates a more pronounced negative hemodynamic effect of PCV during perioperative ventilation. Perioperative ventilation should be protective and hemodynamically safe. In our study, perioperative ASV mode ventilation was characterized by lower VT (16.2%) and ΔP (12.1%) than PCV.

Modern technologies for determining cardiac output (esCCO) allow non-invasive continuous perioperative monitoring and optimize hemodynamic parameters, helping in clinical decision-making. In the group of patients in whom the ASV regimen was used, fewer hemodynamic effects were observed during MV compared to patients in whom PCV ventilation was used. Hemodynamic esCCO monitoring data correlated with ultrasound parameters, indicating high informativeness and reliability of non-invasive monitoring. Hemodynamically-controlled MV avoids over-administration of vasoactive drugs and excessive infusion therapy, reducing the negative impact of cardiopulmonary interactions during MV.

KEY MESSAGES

▪ Most patients require mechanical ventilation during surgery, and there is currently no clear evidence of the benefits of any ventilation mode.

▪ The aim of our study was to evaluate the hemodynamic protective effects of pressure-controlled ventilation (PCV) and adaptive support ventilation (ASV) mode perioperative ventilation based on indicators of non-invasive hemodynamic monitoring.

▪ In our study, ASV mode perioperative ventilation was more protective than PCV mode.

NOTES

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING

None.

ACKNOWLEDGMENTS

We would like to thank the A. Getlik Clinic for Children and Adolescents, Slovak Medical University and University Hospital of Medicine in Bratislava, Slovakia for administrative support and assistance.

AUTHOR CONTRIBUTIONS

Conceptualization: DD, DO. Data curation: all authors. Formal analysis: DD, DO. Methodology: DD, DO. Project administration: DO. Visualization: DD, MM, NO. Writing-original draft: DD, DO. Writing–review & editing: DO, DD.

Figure 1.

Flowchart of patient selection. PCV: pressure-controlled ventilation; ASV: adaptive support ventilation.

Figure 2.

Cardiac output dynamics by estimated continuous cardiac output (esCCO) during surgery compared to baseline by non-invasive monitoring. Group 1: patients who received pressure-controlled ventilation ventilation; Group 2: patients who received adaptive support ventilation ventilation. a) P-value <0.05 compared with baseline level.

Figure 3.

Dynamics of change of ejection fraction at all stages of research in comparison with the initial 100% level. Group 1: patients who received pressure-controlled ventilation ventilation; Group 2: patients who received adaptive support ventilation ventilation. a) P-value <0.05 compared with baseline level.

Table 1.

Demographic indicators of both research groups

Indicator	Group 1 (n=14)	Group 2 (n=18)
Sex
Boy	9	11
Girl	5	7
Age (yr)	15.6±5.3	15.9±4.7
Weight (kg)	68.3±8.9	71.8±10.3
Height (cm)	165.2±8.6	163.9±8.9
Body mass index (kg/m²)	25.4±4.1	26.5±6.4

Values are presented as mean±standard deviation. Group 1: patients who received PCV ventilation; Group 2: patients who received pressure-controlled ventilation ventilation; Group 2: patients who received adaptive support ventilation ventilation.

Table 2.

Duration of surgery and anesthesia, indicators of respiratory mechanics, infusion volume, and ventilation parameters

Variable	Group 1	Group 2
Tidal volume (ml/kg)	7.4±1.2^a)	6.2±0.8^a)
Ppeak (cm H₂O)	17.3±4.4^a)	15.2±3.8^a)
Respiratory mechanics
Cstat (ml/сm H₂O)	48.2±12.8	52.4±13.5
RCexp (sec)	0.68±0.14	0.76±0.12
Intraoperative data
Duration of anesthesia (min)	154.6±34.6^a)	146.0±24.1^a)
Duration of surgery (min)	139.0±27.2	135.4±34.3
Fluid administration (L)	1.9±0.7	1.8±0.4

Values are presented as mean±standard deviation. roup 1: patients who received pressure-controlled ventilation ventilation; Group 2: patients who received adaptive support ventilation ventilation.

Ppeak: peak airway pressure; Cstat: static lung compliance; RCexp: expiratory time constant.

^a) P-value <0.05 when comparing groups.

Table 3.

Data from hemodynamic monitoring by the esCCO method and ventilation status of patients

Variable	Before the start		30 min		60 min		End of the operation		12 Hours after the operation
Variable	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV
Patient gas exchange
PaO₂ (mm Hg)	202.23±29.74	205.34±28.67	140.36±29.23^a)	124.48±22.54^a)	105.52±26.3	102.64±22.43	96.47±23.93	98.72±24.56	88.47±17.69	90.36±16.48
PaCO₂ (mm Hg)	31.45±4.2	35.57±3.32	32.54±3.8	36.27±3.43	32.78±4.4	36.64±3.28	33.72±4.01	36.42±3.21	37.72±3.46	38.42±3.32
SpO₂ (%)	99.4±0.5	99.6±0.3	98.6±2.2	98.8±1.2	98.6±1.3	98.3±1.5	98.7±0.9	99.3±0.6	98.5±1.1	98.7±1.2
Hemodynamic monitoring
MAP (mm Hg)	94.4±9.4	95.3±9.8	82.3±9.4	81.2±9.2	83.5±11.4	85.1±10.8	85.6±12.7	82.8±13.8	92.4±10.6	94.6±9.7
HR (beats/min)	86.6±9.4	89.5±9.2	75.7±9.8	72.6±8.8	72.1±11.4	73.7±13.2	71.4±8.9	72.6±10.6	74.2±12.8	76.4±8.3
esCCO (L/min)	6.1±1.3	6.3±0.8	5.2±0.7^a)	5.5±1.1^a)	5.3±1.4^a)	5.8±1.3^a)	5.4±0.7^a)	5.9±0.9^a)	5.7±1.3^a)	6.1±1.2^a)
esCCI (L/min/m²)	3.9±0.4	3.8±0.8	3.2±0.6	3.1±0.4	3.4±0.7	3.4±0.4	3.5±0.5	3.4±0.3	3.6±0.6	3.5±0.7

Values are presented as mean±standard deviation.

esCCO: estimated continuous cardiac output; PCV: pressure-controlled ventilation; ASV: adaptive support ventilation; PaO₂: partial pressure of oxygen in arterial blood; PaCO₂: partial pressure of carbon dioxide in arterial blood; SpO₂: oxygen saturation; MAP: mean arterial pressure; HR: heart rate; esCCI: estimated continuous cardiac index.

^a) P-value <0.05 when comparing groups at each time point of the study.

Table 4.

Hemodynamic data of ultrasound perioperative monitoring

Variable	Before the start		30 min		60 min		End of the operation		12 Hours after the operation
Variable	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV
Echocardiographic monitoring of hemodynamics
EDV (ml)	127.1±2.1	125.5±1.3	133.9±1.3	142±1.1	141±0.4	143.9±1.0	145.1±0.5	144.4±0.8	146.2±0.6	140±1.1
ESV (ml)	56.1±0.9	54.3±0.7	65.3±0.7	66.3±0.2	67.5±0.6	65.3±0.5	69.5±0.4	63.2±0.5	69.4±0.2	62.1±1.1
SV (ml)	70.9±0.3	70.7±0.5	68.6±0.9	75.7±0.7	73.5±0.6	78.6±0.4	75.6±0.3	81.2±0.5	76.8±0.6	77.9±0.3
EF (%)	55.4±0.3	56.5±0.5	51.2±0.2^a)	53.3±0.6^a)	51.8±0.4^a)	54.6±0.4^a)	52.1±0.1^a)	55.2±0.3^a)	52.5±0.6^a)	55.6±0.7^a)
IVC (mm)	14.5±1.2	14.8±1.1	17.2±0.9	15.7±0.8	16.8±0.8	15.6±0.4	15.5±0.6	15.1±0.5	14.1±0.4	14.9±0.5
Collapse of IVC (%)	≥50	≥50	≥50	≥50	≥50	≥50	≥50	≥50	≥50	≥50
Pressure in PA (mm Hg)	14.2±0.4	14.4±0.2	16.5±0.5	15.9±0.1	16.3±0.4	15.8±0.3	15.7±0.6	15.5±0.4	14.5±0.5	14.1±0.2

Values are presented as mean±standard deviation.

PCV: pressure-controlled; ASV: adaptive support ventilation; EDV: end-diastolic volume; ESV: end-systolic volume; SV: stroke volume; EF: ejection fraction; IVC: inferior vena cava; PA: pulmonary artery.

^a) P-value <0.05 when comparing groups at each time point of the study.

References

1. Güldner A, Kiss T, Serpa Neto A, Hemmes SN, Canet J, Spieth PM, et al. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology 2015;123:692-713.PubMed
2. Lloyd TC Jr. Mechanical cardiopulmonary interdependence. J Appl Physiol Respir Environ Exerc Physiol 1982;52:333-9.Article PubMed
3. Pinsky MR, Matuschak GM, Bernardi L, Klain M. Hemodynamic effects of cardiac cycle-specific increases in intrathoracic pressure. J Appl Physiol (1985) 1986;60:604-12.Article PubMed
4. Abraham E, Yoshihara G. Cardiorespiratory effects of pressure controlled ventilation in severe respiratory failure. Chest 1990;98:1445-9.Article PubMed
5. Poelaert JI, Visser CA, Everaert JA, Koolen JJ, Colardyn FA. Acute hemodynamic changes of pressure-controlled inverse ratio ventilation in the adult respiratory distress syndrome: a transesophageal echocardiographic and Doppler study. Chest 1993;104:214-9.Article PubMed
6. Singer M, Vermaat J, Hall G, Latter G, Patel M. Hemodynamic effects of manual hyperinflation in critically ill mechanically ventilated patients. Chest 1994;106:1182-7.Article PubMed
7. Ishihara H, Sugo Y, Tsutsui M, Yamada T, Sato T, Akazawa T, et al. The ability of a new continuous cardiac output monitor to measure trends in cardiac output following implementation of a patient information calibration and an automated exclusion algorithm. J Clin Monit Comput 2012;26:465-71.Article PubMed PMC PDF
8. Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 2013;369:428-37.Article PubMed
9. PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology; Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet 2014;384:495-503.Article PubMed PMC
10. Ladha K, Vidal Melo MF, McLean DJ, Wanderer JP, Grabitz SD, Kurth T, et al. Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ 2015;351:h3646. Article PubMed PMC
11. Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, et al. Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology 2013;118:1307-21.Article PubMed PDF
12. Orbegozo Cortés D, Puflea F, Donadello K, Taccone FS, Gottin L, Creteur J, et al. Normobaric hyperoxia alters the microcirculation in healthy volunteers. Microvasc Res 2015;98:23-8.Article PubMed
13. Smit B, Smulders YM, de Waard MC, Boer C, Vonk AB, Veerhoek D, et al. Moderate hyperoxic versus near-physiological oxygen targets during and after coronary artery bypass surgery: a randomised controlled trial. Crit Care 2016;20:55. Article PubMed PMC
14. Llitjos JF, Mira JP, Duranteau J, Cariou A. Hyperoxia toxicity after cardiac arrest: what is the evidence? Ann Intensive Care 2016;6:23. Article PubMed PMC PDF
15. Belliato M, Palo A, Pasero D, Iotti GA, Mojoli F, Braschi A. Evaluation of adaptive support ventilation in paralysed patients and in a physical lung model. Int J Artif Organs 2004;27:709-16.Article PubMed PDF
16. Arnal JM, Wysocki M, Nafati C, Donati S, Granier I, Corno G, et al. Automatic selection of breathing pattern using adaptive support ventilation. Intensive Care Med 2008;34:75-81.Article PubMed PDF
17. Dmytro D, Olga K, Mykola M, Sviatoslav K, Kostiantyn D. Successful experience of using adaptive support ventilation (ASV) in the patient with suspected COVID pneumonia. Anaesth Pain Intensiv Care 2021;25:111-7.
18. Nazarchuk OA, Dmytriiev DV, Dmytriiev KD. Clinical, microbiological research of the effectiveness of inhalation use of quaternary ammonium antiseptic in the prevention and treatment of infectious respiratory complications in critically ill patients. Biomed Res Ther 2018;12:2850-62.Article PDF
19. Rose L, Schultz MJ, Cardwell CR, Jouvet P, McAuley DF, Blackwood B. Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children: a cochrane systematic review and meta-analysis. Crit Care 2015;19:48. Article PubMed PMC PDF
20. Kirakli C, Naz I, Ediboglu O, Tatar D, Budak A, Tellioglu E. A randomized controlled trial comparing the ventilation duration between adaptive support ventilation and pressure assist/control ventilation in medical patients in the ICU. Chest 2015;147:1503-9.Article PubMed

Figure & Data

References

Citations

Citations to this article as recorded by

Trends in the dynamics of morbidity and mortality from hypertension in the Republic of Kazakhstan from 2010 to 2019
Yeldos Makhambetchin, Aigerim Yessembekova, Ardak Nurbakyttana, Aza Galayeva, Saparkul Arinova
Polski Merkuriusz Lekarski.2024; 52(1): 95. CrossRef
The effect of Sclerosing drugs on the Tunica albuginea (Experimental study)
Kozhakhmet Kuneshov, Shora Seidinov, Nurpeis Tulezhanov, Fazladin Tеmurov, Shkurulla Massadikov
Research Journal of Pharmacy and Technology.2024; : 2846. CrossRef
Clinical evaluation of ventilation mode on acute exacerbation of chronic obstructive pulmonary disease with respiratory failure
Jun-Jun Wang, Zhong Zhou, Li-Ying Zhang
World Journal of Clinical Cases.2023; 11(26): 6040. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Perioperative hemodynamic protective assessment of adaptive support ventilation usage in pediatric surgical patients

Acute Crit Care. 2022;37(4):636-643. Published online October 19, 2022

DOI: https://doi.org/10.4266/acc.2022.00297

XML Download

Figure

Perioperative hemodynamic protective assessment of adaptive support ventilation usage in pediatric surgical patients

Figure 1. Flowchart of patient selection. PCV: pressure-controlled ventilation; ASV: adaptive support ventilation.

Figure 2. Cardiac output dynamics by estimated continuous cardiac output (esCCO) during surgery compared to baseline by non-invasive monitoring. Group 1: patients who received pressure-controlled ventilation ventilation; Group 2: patients who received adaptive support ventilation ventilation. a) P-value <0.05 compared with baseline level.

Figure 3. Dynamics of change of ejection fraction at all stages of research in comparison with the initial 100% level. Group 1: patients who received pressure-controlled ventilation ventilation; Group 2: patients who received adaptive support ventilation ventilation. a) P-value <0.05 compared with baseline level.

Figure 1.

Figure 2.

Figure 3.

Perioperative hemodynamic protective assessment of adaptive support ventilation usage in pediatric surgical patients

Indicator	Group 1 (n=14)	Group 2 (n=18)
Sex
Boy	9	11
Girl	5	7
Age (yr)	15.6±5.3	15.9±4.7
Weight (kg)	68.3±8.9	71.8±10.3
Height (cm)	165.2±8.6	163.9±8.9
Body mass index (kg/m²)	25.4±4.1	26.5±6.4

Variable	Group 1	Group 2
Tidal volume (ml/kg)	7.4±1.2^a)	6.2±0.8^a)
Ppeak (cm H₂O)	17.3±4.4^a)	15.2±3.8^a)
Respiratory mechanics
Cstat (ml/сm H₂O)	48.2±12.8	52.4±13.5
RCexp (sec)	0.68±0.14	0.76±0.12
Intraoperative data
Duration of anesthesia (min)	154.6±34.6^a)	146.0±24.1^a)
Duration of surgery (min)	139.0±27.2	135.4±34.3
Fluid administration (L)	1.9±0.7	1.8±0.4

Variable	Before the start		30 min		60 min		End of the operation		12 Hours after the operation
Variable	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV
Patient gas exchange
PaO₂ (mm Hg)	202.23±29.74	205.34±28.67	140.36±29.23^a)	124.48±22.54^a)	105.52±26.3	102.64±22.43	96.47±23.93	98.72±24.56	88.47±17.69	90.36±16.48
PaCO₂ (mm Hg)	31.45±4.2	35.57±3.32	32.54±3.8	36.27±3.43	32.78±4.4	36.64±3.28	33.72±4.01	36.42±3.21	37.72±3.46	38.42±3.32
SpO₂ (%)	99.4±0.5	99.6±0.3	98.6±2.2	98.8±1.2	98.6±1.3	98.3±1.5	98.7±0.9	99.3±0.6	98.5±1.1	98.7±1.2
Hemodynamic monitoring
MAP (mm Hg)	94.4±9.4	95.3±9.8	82.3±9.4	81.2±9.2	83.5±11.4	85.1±10.8	85.6±12.7	82.8±13.8	92.4±10.6	94.6±9.7
HR (beats/min)	86.6±9.4	89.5±9.2	75.7±9.8	72.6±8.8	72.1±11.4	73.7±13.2	71.4±8.9	72.6±10.6	74.2±12.8	76.4±8.3
esCCO (L/min)	6.1±1.3	6.3±0.8	5.2±0.7^a)	5.5±1.1^a)	5.3±1.4^a)	5.8±1.3^a)	5.4±0.7^a)	5.9±0.9^a)	5.7±1.3^a)	6.1±1.2^a)
esCCI (L/min/m²)	3.9±0.4	3.8±0.8	3.2±0.6	3.1±0.4	3.4±0.7	3.4±0.4	3.5±0.5	3.4±0.3	3.6±0.6	3.5±0.7

Variable	Before the start		30 min		60 min		End of the operation		12 Hours after the operation
Variable	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV	PCV	ASV
Echocardiographic monitoring of hemodynamics
EDV (ml)	127.1±2.1	125.5±1.3	133.9±1.3	142±1.1	141±0.4	143.9±1.0	145.1±0.5	144.4±0.8	146.2±0.6	140±1.1
ESV (ml)	56.1±0.9	54.3±0.7	65.3±0.7	66.3±0.2	67.5±0.6	65.3±0.5	69.5±0.4	63.2±0.5	69.4±0.2	62.1±1.1
SV (ml)	70.9±0.3	70.7±0.5	68.6±0.9	75.7±0.7	73.5±0.6	78.6±0.4	75.6±0.3	81.2±0.5	76.8±0.6	77.9±0.3
EF (%)	55.4±0.3	56.5±0.5	51.2±0.2^a)	53.3±0.6^a)	51.8±0.4^a)	54.6±0.4^a)	52.1±0.1^a)	55.2±0.3^a)	52.5±0.6^a)	55.6±0.7^a)
IVC (mm)	14.5±1.2	14.8±1.1	17.2±0.9	15.7±0.8	16.8±0.8	15.6±0.4	15.5±0.6	15.1±0.5	14.1±0.4	14.9±0.5
Collapse of IVC (%)	≥50	≥50	≥50	≥50	≥50	≥50	≥50	≥50	≥50	≥50
Pressure in PA (mm Hg)	14.2±0.4	14.4±0.2	16.5±0.5	15.9±0.1	16.3±0.4	15.8±0.3	15.7±0.6	15.5±0.4	14.5±0.5	14.1±0.2

Table 1. Demographic indicators of both research groups

Table 2. Duration of surgery and anesthesia, indicators of respiratory mechanics, infusion volume, and ventilation parameters

Values are presented as mean±standard deviation. roup 1: patients who received pressure-controlled ventilation ventilation; Group 2: patients who received adaptive support ventilation ventilation.

Ppeak: peak airway pressure; Cstat: static lung compliance; RCexp: expiratory time constant.

P-value <0.05 when comparing groups.

Table 3. Data from hemodynamic monitoring by the esCCO method and ventilation status of patients

Values are presented as mean±standard deviation.

P-value <0.05 when comparing groups at each time point of the study.

Table 4. Hemodynamic data of ultrasound perioperative monitoring

Values are presented as mean±standard deviation.

P-value <0.05 when comparing groups at each time point of the study.